{"id":"W2110966639","doi":"10.1007/s11060-015-1958-z","title":"A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients","year":2015,"lang":"en","type":"article","venue":"Journal of Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bevacizumab; Temozolomide; Medicine; Erlotinib; Clinical endpoint; Internal medicine; Oncology; Phases of clinical research; Surgery; Radiation therapy; Gastroenterology; Clinical trial; Chemotherapy; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001311199,0.001277677,0.003094915,0.0004547483,0.0004639947,0.001127795,0.0007833104,0.001203413,0.002950742],"category_scores_gemma":[0.0007945101,0.0007392235,0.00173812,0.0004678897,0.0009535708,0.001218562,0.0003735186,0.003524287,0.0007166041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001255544,"about_ca_system_score_gemma":0.001572048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001856578,"about_ca_topic_score_gemma":0.005251832,"domain_scores_codex":[0.9995005,0.0001899841,0.00002394677,0.0001120508,0.00003608159,0.0001374149],"domain_scores_gemma":[0.9994321,0.00007695764,0.00009901461,0.00004880267,0.00003355643,0.0003094385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8119963,0.05703052,0.006995993,0.0005449039,0.002165258,0.0001918231,0.0003128083,0.002163078,0.03199006,0.0002397443,0.002440249,0.08392926],"study_design_scores_gemma":[0.4842785,0.4870735,0.0198085,0.00003708322,0.001301752,0.0002445365,0.0001254222,0.001086289,0.002834526,0.0002105077,0.002946016,0.00005335851],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961773,0.00158178,0.000223252,0.0002587033,0.00009821939,0.0006265127,0.0003758985,0.00003317376,0.0006252723],"genre_scores_gemma":[0.9930101,0.001630709,0.0007676142,0.0005515809,0.0001254604,0.0008952299,0.001324088,0.00002707454,0.001668062],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003094915,"threshold_uncertainty_score":0.009871185,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02819120026437085,"score_gpt":0.3404430708996272,"score_spread":0.3122518706352564,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}